Cargando…

Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up

Meningiomas are common benign tumors with accepted treatment approaches and usually don't challenge healthcare specialists. We present a case of a huge unresectable hemicranial meningioma, which was successfully treated with hypofractionated irradiation. A male patient, sixty-two years of age,...

Descripción completa

Detalles Bibliográficos
Autores principales: Galkin, Mikhail, Golanov, Andrey V., Antipina, Natalia, Gorlachev, Gennady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689568/
https://www.ncbi.nlm.nih.gov/pubmed/26719827
http://dx.doi.org/10.7759/cureus.384
_version_ 1782406868610580480
author Galkin, Mikhail
Golanov, Andrey V.
Antipina, Natalia
Gorlachev, Gennady
author_facet Galkin, Mikhail
Golanov, Andrey V.
Antipina, Natalia
Gorlachev, Gennady
author_sort Galkin, Mikhail
collection PubMed
description Meningiomas are common benign tumors with accepted treatment approaches and usually don't challenge healthcare specialists. We present a case of a huge unresectable hemicranial meningioma, which was successfully treated with hypofractionated irradiation. A male patient, sixty-two years of age, suffered for over 12 years from headaches, facial deformity, right eye displacement, right eye movement restriction, right-sided ptosis, and facial hypoesthesia. MRI and CT studies revealed an extended hemicranial meningioma. Prior to irradiation, the patient underwent four operations. Eventually, the tumor was irradiated with the CyberKnife in August 2009. Tumor volume composed 1085 cc. The mean dose of 35.3 Gy was delivered in 7 fractions (31.5 Gy at 72% isodose line comprising 95% of tumor volume). The patient was followed during six years and experienced only mild (Grade 1-2 CTCAE) acute skin and mucosa reactions. During the follow-up period, we observed target volume shrinkage for 17% (for 26% after excluding hyperostosis) and regression of intracranial hypertension signs. Due to the extreme volume and complex shape of the tumor, spreading along the surface of the hemisphere as well as an optic nerve involvement, the case presented would not be generally considered suitable for irradiation, especially for hypofractionation. We regard this clinical situation not as a treatment recommendation, but as a demonstration of the underestimated possibilities of hypofractionation regimen and CyberKnife system, both of which are limited with our habit of conventional treatments.
format Online
Article
Text
id pubmed-4689568
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-46895682015-12-30 Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up Galkin, Mikhail Golanov, Andrey V. Antipina, Natalia Gorlachev, Gennady Cureus Radiation Oncology Meningiomas are common benign tumors with accepted treatment approaches and usually don't challenge healthcare specialists. We present a case of a huge unresectable hemicranial meningioma, which was successfully treated with hypofractionated irradiation. A male patient, sixty-two years of age, suffered for over 12 years from headaches, facial deformity, right eye displacement, right eye movement restriction, right-sided ptosis, and facial hypoesthesia. MRI and CT studies revealed an extended hemicranial meningioma. Prior to irradiation, the patient underwent four operations. Eventually, the tumor was irradiated with the CyberKnife in August 2009. Tumor volume composed 1085 cc. The mean dose of 35.3 Gy was delivered in 7 fractions (31.5 Gy at 72% isodose line comprising 95% of tumor volume). The patient was followed during six years and experienced only mild (Grade 1-2 CTCAE) acute skin and mucosa reactions. During the follow-up period, we observed target volume shrinkage for 17% (for 26% after excluding hyperostosis) and regression of intracranial hypertension signs. Due to the extreme volume and complex shape of the tumor, spreading along the surface of the hemisphere as well as an optic nerve involvement, the case presented would not be generally considered suitable for irradiation, especially for hypofractionation. We regard this clinical situation not as a treatment recommendation, but as a demonstration of the underestimated possibilities of hypofractionation regimen and CyberKnife system, both of which are limited with our habit of conventional treatments. Cureus 2015-11-20 /pmc/articles/PMC4689568/ /pubmed/26719827 http://dx.doi.org/10.7759/cureus.384 Text en Copyright © 2015, Galkin et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Galkin, Mikhail
Golanov, Andrey V.
Antipina, Natalia
Gorlachev, Gennady
Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title_full Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title_fullStr Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title_full_unstemmed Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title_short Successful CyberKnife Irradiation of 1000 cc Hemicranial Meningioma: 6-year Follow-up
title_sort successful cyberknife irradiation of 1000 cc hemicranial meningioma: 6-year follow-up
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689568/
https://www.ncbi.nlm.nih.gov/pubmed/26719827
http://dx.doi.org/10.7759/cureus.384
work_keys_str_mv AT galkinmikhail successfulcyberknifeirradiationof1000cchemicranialmeningioma6yearfollowup
AT golanovandreyv successfulcyberknifeirradiationof1000cchemicranialmeningioma6yearfollowup
AT antipinanatalia successfulcyberknifeirradiationof1000cchemicranialmeningioma6yearfollowup
AT gorlachevgennady successfulcyberknifeirradiationof1000cchemicranialmeningioma6yearfollowup